Skip to search formSkip to main contentSkip to account menu

atomoxetine

Known as: Tomoxetine, Tomoxetina, Tomoxetinum 
National Institutes of Health

Related topics

Related topics

6 relations
Angle Closure GlaucomaAtomoxetine:MCnc:Pt:Ser/Plas:QnAttention deficit hyperactivity disorderHypersensitivity

Narrower (2)

Stratteraatomoxetine hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies.
2010
2010
Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.
BACKGROUND Previous Dutch studies showed increasing psychostimulant use, especially methylphenidate immediate-release (MPH-IR… 
2009
2009
Atomoxetine Attenuates Dextroamphetamine Effects in Humans
Background: Although preclinical studies support the contribution of the noradrenergic system activation in mediating the acute… 
Review
2009
Review
2009
Atomoxetine and Cerebrovascular Outcomes in Adults
Objective: The aim of this study was to estimate the association between atomoxetine and cerebrovascular accident (CVA) and… 
2006
2006
Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
Atomoxetine is marketed as a nonstimulant medication indicated for the treatment of attention-deficit/hyperactivity disorder in… 
2006
2006
Low-Dose Atomoxetine for Maintenance Treatment of Attention-Deficit/Hyperactivity Disorder
OBJECTIVE. Data from acute studies of atomoxetine in patients with attention-deficit/hyperactivity disorder suggest that a dose… 
2005
2005
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
We recently reported that selective inhibitors of neuronal transport of norepinephrine (NE), desipramine and nisoxetine, reversed… 
2005
2005
Wall Street and clinical trials.
Should physicians sell their expertise and knowledge about clinical research to Wall Street? Dr. Robert Steinbrook reports that… 
2003
2003
Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential
RationaleOne of the common neurochemical features of many drugs of abuse is their ability to directly or indirectly enhance… 
1995
1995
Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)